van der Zanden, Tjitske M.
~ 0  results:
Search for persons X
?
1

Best Evidence-Based Dosing Recommendations for Dexmedetomid..:

Freriksen, Jolien J. M ; van der Zanden, Tjitske M ; Holsappel, Inge G. A..
https://research.rug.nl/en/publications/5daed748-758f-407e-b1e9-55d79e840972.  , 2022
 
?
3

Monatsschrift Kinderheilkunde / Evidenzbasierte Off-label-A..:

Male, Christoph ; Neubert, Antje ; Grytli, Helene...
vignette : https://repositorium.meduniwien.ac.at/titlepage/urn/urn:nbn:at:at-ubmuw:3-55956/128.  , 2022
 
?
4

Benefit-Risk Assessment of Off-Label Drug Use in Children:T..:

van der Zanden, Tjitske M ; Mooij, lumc ; Vet, Nienke J...
van der Zanden , T M , Mooij , L , Vet , N J , Neubert , A , Rascher , W , Lagler , F B , Male , C , Grytli , H , Halvorsen , T , de Hoog , M & de Wildt , S N 2021 , ' Benefit-Risk Assessment of Off-Label Drug Use in Children : The Bravo Framework ' , Clinical Pharmacology and Therapeutics , vol. 110 , no. 4 , pp. 952-965 . https://doi.org/10.1002/cpt.2336.  , 2021
 
?
5

Rapid Implementation of Model-Based Dosing Recommendations ..:

De Wildt, Saskia N ; Verscheijden, Laurens F.M ; Van Der Zanden, Tjitske M
De Wildt , S N , Verscheijden , L F M & Van Der Zanden , T M 2021 , ' Rapid Implementation of Model-Based Dosing Recommendations during the Coronavirus Disease 2019 Pandemic ' , JAMA Pediatrics , vol. 175 , no. 4 , pp. 432-433 . https://doi.org/10.1001/jamapediatrics.2020.5395.  , 2021
 
1-15